E
enGene Therapeutics Inc. (ENGN)
NCM – Real Time Price. Currency in USD
1.44
-0.05 (-3.36%)
At close: May 12, 2026, 4:00 PM EDT
1.48
+0.04 (2.75%)
After-hours: May 12, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.44
-0.05 (-3.36%)
At close: May 12, 2026, 4:00 PM EDT
1.48
+0.04 (2.75%)
After-hours: May 12, 2026, 7:57 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.75 | 6.05 | 10 | |
| Quick ratio | 11.75 | 5.63 | 10 | |
| Debt to Equity | 0.12 | 0.30 | 9.0 | |
| Debt to Assets | 0.10 | 1.04 | 9.0 | |
| Interest coverage | -42.60 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | -175K | -323K | -509K | -596K |
| Operating Income | -2M | -26M | -62M | -123M | -128M |
| Net Income | 31K | -100M | -55M | -117M | -122M |
| EBITDA | -2M | -26M | -62M | -123M | -127M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 8.27 | 3.5 |
| Next quarter | N/A | 11.84 | 4.0 |
| Current year | N/A | 14.09 | 4.5 |
| Next year | N/A | 1.33 | 2.0 |
| Weighted average score | 3.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 21.46 | 39.73 | -14.39 | 7.8 |
| Y/Y | 999 | -20.85 | 8.33 | -11.77 | 4.5 |
| 3y average | 999 | -108451.67 | 21.08 | -1139.89 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 4.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $36.6M significantly exceed its total debt $33.5M, ensuring strong financial flexibility
Total current assets $289.2M exceed Total current liabilities $24.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-42.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$29.1M limits the company's ability to reinvest or pay down debt